Article

Improving Outcomes in Diabetic Macular Edema: The Impact of New Therapies in Managed Care

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Marry Vuong, PharmD, BCPPS
Dr Elise Tremblay
Related Content
eye health in a clinical setting-Microgen-stock.adobe.com
August 19th 2025

Semaglutide, Tirzepatide Linked to Small Increase in Eye Disorder Risk

Pearl Steinzor
Managed Care Cast logo
August 19th 2025

Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO

Brooke McCormick
Credit Score | Image credit: wirojsid - stock.adobe.com
August 19th 2025

Type 2 Diabetes Linked to Poor Credit, Financial Distress

Pearl Steinzor
Managed Care Cast graphic
August 19th 2025

How Can Employers Leverage the DPP to Improve Diabetes Rates?

PFAS | Image credit: Vodkaz - stock.adobe.com
August 19th 2025

PFAS Exposure Linked to Increased Risk of Type 2 Diabetes, Study Finds

Pearl Steinzor
Diabetes monitoring | Image credit: abidika - stock.adobe.com
August 19th 2025

SGLT2i-Induced Erythrocytosis Not Linked to Clots in Type 2 Diabetes

Pearl Steinzor

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo